Latest News Israel

Clal Biotech setting up NIS 225m medical devices fund

Share |
Friday, May 27th, 2011

As reported in Globes:

Clal Biotechnology Industries Ltd. (TASE: CBI), the life sciences investment of Nochi Dankner-controlled IDB Holding Corp. Ltd. (TASE:IDBH), today announced that it will provide 40-60% of the NIS 225 million medical devices investment fund it is setting up with Israeli institutional investors. The company added that it is in talks with institutional investors for this purpose, as part of the government incentives program for institutional investors to invest in high tech.

Clal Biotech made no transactions in the first quarter, resulting in a net loss from current operations of NIS 30.8 million, compared with a net loss of NIS 32.8 million for the corresponding quarter of 2010.

Revenue was nearly halved to NIS 6.6 million for the first quarter from NIS 12.2 million for the corresponding quarter. Revenue from licenses and rent rose to NIS 1.2 million for the first quarter from NIS 861,000 for the corresponding quarter. The company had NIS 177 million in cash and cash equivalents at the end of March.

read more here